BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30009333)

  • 1. The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.
    Martami F; Razeghi Jahromi S; Togha M; Ghorbani Z; Seifishahpar M; Saidpour A
    Neurol Sci; 2018 Oct; 39(10):1741-1749. PubMed ID: 30009333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Inflammatory State in Migraineurs: A Case-control Study.
    Togha M; Razeghi Jahromi S; Ghorbani Z; Ghaemi A; Rafiee P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):83-90. PubMed ID: 32534515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study.
    Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R
    Cephalalgia; 2018 Apr; 38(5):904-911. PubMed ID: 28677995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.
    Abdolahi M; Tafakhori A; Togha M; Okhovat AA; Siassi F; Eshraghian MR; Sedighiyan M; Djalali M; Mohammadzadeh Honarvar N; Djalali M
    Immunogenetics; 2017 Jun; 69(6):371-378. PubMed ID: 28478481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low leptin levels in migraine: a case control study.
    Guldiken B; Guldiken S; Demir M; Turgut N; Tugrul A
    Headache; 2008 Jul; 48(7):1103-7. PubMed ID: 18547265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial.
    Martami F; Togha M; Seifishahpar M; Ghorbani Z; Ansari H; Karimi T; Jahromi SR
    Cephalalgia; 2019 Jun; 39(7):841-853. PubMed ID: 30621517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients.
    Güzel I; Taşdemir N; Celik Y
    Neurol Neurochir Pol; 2013; 47(4):357-62. PubMed ID: 23986426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of tumor necrosis factor alpha in a subclass of menstrual migraineurs.
    Mueller L; Gupta AK; Stein TP
    Headache; 2001 Feb; 41(2):129-37. PubMed ID: 11251696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum prolactin level may indicate more migraine attack frequency.
    Togha M; Nematgorgani S; Ghorbani Z; Rafiee P; Haghighi S
    Brain Behav; 2023 Jul; 13(7):e3063. PubMed ID: 37190874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proinflammatory cytokines in children with idiopathic headache].
    Gergont A; Kaciński M; Kwinta P
    Przegl Lek; 2005; 62(11):1269-75. PubMed ID: 16512619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of simple inflammatory blood parameters in patients with migraine.
    Yazar HO; Yazar T; Aygün A; Kaygisiz Ş; Kirbaş D
    Ir J Med Sci; 2020 May; 189(2):677-683. PubMed ID: 31758522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation.
    Yilmaz IA; Ozge A; Erdal ME; Edgünlü TG; Cakmak SE; Yalin OO
    Pain Med; 2010 Apr; 11(4):492-7. PubMed ID: 20113413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
    Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R
    Headache; 2018 Jan; 58(1):78-87. PubMed ID: 29131327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbance and affective comorbidity among episodic migraineurs.
    Walters AB; Hamer JD; Smitherman TA
    Headache; 2014 Jan; 54(1):116-24. PubMed ID: 23808359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of essential fatty acid intakes and serum levels of inflammatory factors between asthmatic and healthy adults: a case- control study.
    Haidari F; Mohammadshahi M; Borsi SH; Haghighizadeh MH; Malgard S
    Iran J Allergy Asthma Immunol; 2014 Oct; 13(5):335-42. PubMed ID: 25150074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
    Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the role of adipokines in chronic migraine.
    Rubino E; Vacca A; Govone F; Gai A; Boschi S; Zucca M; De Martino P; Gentile S; Pinessi L; Rainero I
    Cephalalgia; 2017 Oct; 37(11):1067-1073. PubMed ID: 27553954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Bilirubin and Their Association With C-Reactive Protein in Patients With Migraine.
    Peng YF; Xie LQ; Xiang Y; Xu GD
    J Clin Lab Anal; 2016 Nov; 30(6):982-985. PubMed ID: 26996761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
    Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
    Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.